AXA IM’s structured finance team launches Partner Capital Solutions VIII

AXA IM’s structured finance team launches Partner Capital Solutions VIII

AXA Investment Managers (AXA IM) has launched the eighth fund of its Partner Capital Solutions strategy.

Similar to previous funds in the range, AXA IM Partner Capital Solutions VIII seeks to offer opportunities to clients who want to gain exposure to performing credit from traditional core lending activities of banks including small to large corporates. The fund leverages on AXA IM’s ability to generate exposure to diversified credit portfolios that are otherwise difficult to access, and that require strong sourcing capabilities combined with robust credit skills.

The seventh fund, launched in 2017, fully deployed its 1.2 billion euros of assets under management before the end of 2019 thanks to a strong pipeline of bilateral opportunities. In 2019, the regulatory capital (RegCap) market reached a new record issuing more than 130 billion euros of underlying portfolios, encompassing roughly 60 different transactions.

AXA IM Partner Capital Solutions VIII conducted a successful first closing mainly with existing investors, including pension funds, insurance companies and family offices, willing to benefit from the end of year pipeline.

Commenting on the launch Deborah Shire, Global Head of Structured Finance at AXA Investment Managers, said:

“The RegCap market has been transformed into a full-fledged alternative investment opportunity, increasing its volume in recent years. For our investors this is an interesting way to diversify direct lending portfolios by getting access to granular loan books that are the banks’ core activities. These can include, for example, exposures to SMEs’ loans or to revolving credit facilities granted to large corporates, which are not commonly available outside the banking system. AXA IM Partner Capital Solutions VIII will offer diversification and provide attractive opportunities to clients.”

AXA IM Partner Capital Solutions VIII is managed by AXA Investment Managers, Inc. AXA IM’s Structured Finance investment team manages around EUR 45.7 billion* in global assets across the non-traditional credit spectrum . For more than 20 years, it has provided bespoke solutions and investments in alternative credit and structured finance for large investors, typically looking for stable and predictable returns. AXA IM Structured Finance originates opportunities across the alternative credit spectrum to provide clients with opportunities for sourcing, diversification and spread pick-up.

Contacts

Jamie Wynn-Williams

+44 20 7003 2680

Jamie.Wynn-Williams@axa-im.com

Ellis Ford

+44 20 7003 1225

Ellis.Ford@axa-im.com

Hélène Caillet

+33 1 44 45 88 06

Helene.Caillet@axa-im.com

Notes to Editors

*as at 30 September 2019

About AXA Investment Managers

AXA Investment Managers (AXA IM) is an active, long-term, global multi-asset investor. We work with clients today to provide the solutions they need to help build a better tomorrow for their investments, while creating a positive change for the world in which we all live. With approximately €801 billion in assets under management as at end of September 2019, AXA IM employs over 2,350 employees around the world and operates out of 30 offices across 21 countries. AXA IM is part of the AXA Group, a world leader in financial protection and wealth management.

Visit our website: www.axa-im.com 

Follow us on Twitter: https://twitter.com/AXAIM

Visit our media centre: www.axa-im.com/en/media-centre

Disclaimer

AXA Investment Managers UK Limited is authorised and regulated by the Financial Conduct Authority. This press release is as dated. This does not constitute a Financial Promotion as defined by the Financial Conduct Authority and is for information purposes only. The content herein may not be suitable for retail clients. No financial decisions should be made on the basis of the information provided. Strategies mentioned may not be registered or available in your jurisdiction. This communication is not an offer to buy or sell any investments, products or services and should not be considered as a solicitation or as investment, legal or tax advice.

Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for independent advice.

Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 7 Newgate Street, London EC1A 7NX.